EPS Bio Technology Corp. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was TWD 459.346 million compared to TWD 414.217 million a year ago. Operating income was TWD 27.731 million compared to TWD 9.839 million a year ago. Net income was TWD 18.438 million compared to TWD 15.797 million a year ago. Basic earnings per share was TWD 0.77 compared to TWD 0.66 a year ago.